Katherine Ross-Driscoll

Katherine Ross-Driscoll

Auto-generated profile, based on publicly available information

Katherine Ross-Driscoll

Division of Transplantation, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2019 in Cancer
Verified
Journal Article
Closed access
PDF file
KRKatherine H. Ross
Katherine H. Ross
KGKeerthi Gogineni
Keerthi Gogineni
PSPreeti D. Subhedar
Preeti D. Subhedar
JLJolinta Y. Lin
Jolinta Y. Lin
LMLauren E. McCullough
Lauren E. McCullough

30 January 2023 in American Journal of Transplantation
Verified
Journal Article
Open access
SDSasha Deutsch-Link
Sasha Deutsch-Link
TBTherese Bittermann
Therese Bittermann
LNLauren Nephew
Lauren Nephew
KRKatherine Ross-Driscoll
Katherine Ross-Driscoll
EWEthan M. Weinberg
Ethan M. Weinberg
MSMarina Serper
Marina Serper
Health disparities have been well-described in all stages of the liver transplantation (LT) process. Using data from psychosocial evaluations and the Stanford Integrated Psychosocial Assessment, our objective was to investigate potential racial and ethnic inequities in overall LT waitlisting and not waitlisting for medical or psychosocial reasons. In a cohort of 2271 candidates evaluated for LT from 2014 to 2021 and with 1-8 years of follow-up, no significant associations were noted between race/ethnicity and overall waitlisting and not waitlisting for medical reasons. However, compared with White race, Black race (odds ratio [OR], 1.65; 95% confidence interval [CI], 1.07-2.56) and Hispanic/Latinx ethnicity (OR, 2.10; 95% CI, 1.16-3.78) were associated with not waitlisting for psychosocial reasons. After adjusting for sociodemographic variables, the relationship persisted in both populations: Black (OR, 1.95; 95% CI, 1.12-3.38) and Hispanic/Latinx (OR, 2.29; 95% CI, 1.08-4.86) (reference group, White). High-risk Stanford Integrated Psychosocial Assessment scores were more prevalent in Black and Hispanic/Latinx patients, likely reflecting upstream factors and structural racism. Health systems and LT centers should design programs to combat these disparities and improve equity in access to LT.

11 December 2020 in Liver Transplantation
Verified
Journal Article
Closed access
KRKatherine Ross‐Driscoll
Katherine Ross‐Driscoll
MKMichael Kramer
Michael Kramer
RLRaymond Lynch
Raymond Lynch
LPLaura Plantinga
Laura Plantinga
JWJoel Wedd
Joel Wedd
RPRachel Patzer
Rachel Patzer

15 September 2020 in American Journal of Transplantation
Verified
Journal Article
Open access
SPSudeshna Paul
Sudeshna Paul
TMTaylor Melanson
Taylor Melanson
SMSumit Mohan
Sumit Mohan
KRKatherine Ross-Driscoll
Katherine Ross-Driscoll
LMLaura McPherson
Laura McPherson
RPRachel E. Patzer
Rachel E. Patzer
Kidney transplant program performance in the United States is commonly measured by posttransplant outcomes. Inclusion of pretransplant measures could provide a more comprehensive assessment of transplant program performance and necessary information for patient decision-making. In this study, we propose a new metric, the waitlisting rate, defined as the ratio of patients who are waitlisted in a center relative to the person-years referred for evaluation to a program. Furthermore, we standardize the waitlisting rate relative to the state average in Georgia, North Carolina, and South Carolina. The new metric was used as a proof-of-concept to assess transplant-program access compared to the existing transplant rate metric. The study cohorts were defined by linking 2017 United States Renal Data System (USRDS) data with transplant-program referral data from the Southeastern United States between January 1, 2012 and December 31, 2016. Waitlisting rate varied across the 9 Southeastern transplant programs, ranging from 10 to 22 events per 100 patient-years, whereas the program-specific waitlisting rate ratio ranged between 0.76 and 1.33. Program-specific waitlisting rate ratio was uncorrelated with the transplant rate ratio (r = −.15, 95% CI, −0.83 to 0.57). Findings warrant collection of national data on early transplant steps, such as referral, for a more comprehensive assessment of transplant program performance and pretransplant access.

22 February 2022 in American Journal of Transplantation
Verified
Journal Article
Open access
BDBrianna L. Doby
Brianna L. Doby
KRKatie Ross-Driscoll
Katie Ross-Driscoll
SYSharon Yu
Sharon Yu
MGMiriam Godwin
Miriam Godwin
KLKevin J. Lee
Kevin J. Lee
RLRaymond J. Lynch
Raymond J. Lynch
Questions have arisen around new metrics for organ procurement organizations (OPO) due to the perception that low-performing OPOs may be limited by local centers’ acceptance of marginal organs. We reviewed 2013–2019 Organ Procurement and Transplantation Network (OTPN) and National Centers for Health Statistics (NCHS) data to explore the relationship between objectively measured OPO performance and utilization of deceased donor kidneys. We found that although donor recovery declined with rising age and kidney donor profile index (KDPI), OPO performance differences were evident within each age/KDPI group. By contrast, the number of discards per donor did not vary with OPO performance. Centers in donor service areas (DSAs) with lower-performing OPOs had higher local utilization and greater import of high-KDPI kidneys than did those with higher-performing OPOs. Lower rates of donor availability relative to waitlist additions may contribute to observed center acceptance behavior. Differences in center-level performance were highly visible in Scientific Registry of Transplant Recipients (SRTR) organ acceptance metrics, while SRTR OPO metrics did not detect large or persistent variation in procurement performance. Cumulatively, our findings suggest that objective measures of procurement performance can inform discussions of organ utilization, allowing for alignment of metrics in all elements of the procurement-transplantation system.

9 February 2021 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
BDBrianna L. Doby
Brianna L. Doby
KRKatie Ross-Driscoll
Katie Ross-Driscoll
MSMarion Shuck
Marion Shuck
MWMatthew Wadsworth
Matthew Wadsworth
CDChristine M. Durand
Christine M. Durand
RLRaymond J. Lynch
Raymond J. Lynch
The Centers for Medicare and Medicaid Services announced changes to the Final Rule for organ procurement organizations (OPO) in November 2020, after a 23‐month period of public debate. One concern among transplant stakeholders was that public focus on OPO underperformance would harm deceased donation. Using CDC‐WONDER data, we studied whether donation performance dropped during the era of public debate about OPO reform (December 2018 – February 2020). Overall OPO performance as measured relative to cause, age, and location‐consistent deaths rose by 12.3% in 2019, compared to a median annual change of 2.5% 2009‐2019. Organ recoveries exceeded seasonally‐adjusted forecasts by 4.2% in the first half of 2019, by 8.1% following the Executive Order issuing a mandate for OPO metric reform, and by 14.1% between the Notice of Public Rule Making and the onset of COVID‐19 related systemic disruptions. We describe changes in donor phenotype in the period of increased performance; improvement was greatest for older and donation after cardiac death donors, and among decedents who did not have a drug‐related mechanism of death. In summary, performance during an era of intense public debate and proposed regulatory changes yielded 692 additional donors over expectations, and no detriment to organ donation was observed.